Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00179049 |
Recruitment Status
:
Completed
First Posted
: September 15, 2005
Last Update Posted
: December 15, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Hematopoietic Stem Cell Transplantation Graft vs Host Disease |
Study Type : | Observational |
Estimated Enrollment : | 100 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | Evaluation of Immunoregulatory Cells in Hematopoietic Stem Cell Transplant (HSCT) |
Study Start Date : | April 2003 |
Actual Study Completion Date : | April 2008 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 70 Years (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patients 18-70 years old undergoing either autologous transplant or allogeneic transplant for various hematologic conditions
Exclusion Criteria:
- Patients < 18 or > 70 years old undergoing either autologous transplant or allogeneic transplant

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00179049
United States, Tennessee | |
Vanderbilt University Medical Center | |
Nashville, Tennessee, United States, 37232-5505 |
Principal Investigator: | Adetola A Kassim, M.D. | Vanderbilt University |
Responsible Party: | Adetola A. Kassim, MD, Vanderbilt University |
ClinicalTrials.gov Identifier: | NCT00179049 History of Changes |
Other Study ID Numbers: |
BMT 030261 |
First Posted: | September 15, 2005 Key Record Dates |
Last Update Posted: | December 15, 2008 |
Last Verified: | December 2008 |
Keywords provided by Vanderbilt University:
T-Lymphocyte Subsets |
Additional relevant MeSH terms:
Graft vs Host Disease Immune System Diseases |